1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Endometriosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feola, M; Lox, CD; McGunegle, DE; Simoni, G; Simoni, J | 1 |
| Bourque, J; Falcone, T; Hemmings, R; Langlais, J; Lepage, N; Miron, P | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Endometriosis
| Article | Year |
|---|---|
Cytokines and PAF release from human monocytes and macrophages: effect of hemoglobin and contaminants.
Topics: Animals; Blood Substitutes; Cattle; Cross-Linking Reagents; Cytokines; Drug Contamination; Endometriosis; Endotoxins; Female; Hemoglobins; Humans; In Vitro Techniques; Lipids; Macrophages, Peritoneal; Microscopy, Electron; Monocytes; Platelet Activating Factor; Polymers | 1994 |
Platelet-activating factor acetylhydrolase activity in peritoneal fluids of women with endometriosis.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Albumins; Ascitic Fluid; Cholesterol; Endometriosis; Female; Humans; Phospholipases A; Platelet Activating Factor | 1993 |